Alphabet as of March 31, 2023
Portfolio Holdings for Alphabet
Alphabet holds 49 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
UiPath Cl A (PATH) | 13.7 | $247M | 14M | 17.56 | |
Prime Medicine (PRME) | 9.1 | $163M | 13M | 12.30 | |
Crowdstrike Hldgs Cl A (CRWD) | 8.9 | $160M | 1.2M | 137.26 | |
Oscar Health Cl A (OSCR) | 8.7 | $157M | 24M | 6.54 | |
Verve Therapeutics (VERV) | 8.4 | $152M | 11M | 14.42 | |
Dex (DXCM) | 8.1 | $145M | 1.3M | 116.18 | |
Planet Labs PBC Com Cl A (PL) | 7.0 | $126M | 32M | 3.93 | |
Eqrx | 5.1 | $93M | 48M | 1.94 | |
Snowflake Cl A (SNOW) | 4.6 | $83M | 536k | 154.29 | |
Duolingo Cl A Com (DUOL) | 4.1 | $75M | 524k | 142.59 | |
Gitlab Class A Com (GTLB) | 3.7 | $66M | 1.9M | 34.29 | |
Freshworks Class A Com (FRSH) | 3.4 | $62M | 4.0M | 15.36 | |
Robinhood Mkts Com Cl A (HOOD) | 2.7 | $48M | 4.9M | 9.71 | |
Lyft Cl A Com (LYFT) | 1.9 | $34M | 3.7M | 9.27 | |
Relay Therapeutics (RLAY) | 1.4 | $26M | 1.6M | 16.47 | |
Desktop Metal Com Cl A | 1.4 | $25M | 11M | 2.30 | |
Benson Hill Common Stock | 1.0 | $18M | 15M | 1.15 | |
23andMe Holding Class A Com (ME) | 0.9 | $15M | 6.7M | 2.28 | |
Lyell Immunopharma (LYEL) | 0.8 | $14M | 5.9M | 2.36 | |
Illumina (ILMN) | 0.7 | $12M | 54k | 232.55 | |
Monte Rosa Therapeutics (GLUE) | 0.6 | $11M | 1.5M | 7.79 | |
Rapt Therapeutics (RAPT) | 0.5 | $9.9M | 540k | 18.35 | |
Beam Therapeutics (BEAM) | 0.5 | $9.8M | 322k | 30.62 | |
Sana Biotechnology (SANA) | 0.5 | $9.2M | 2.8M | 3.27 | |
Adagio Therapeutics (IVVD) | 0.4 | $6.8M | 5.7M | 1.20 | |
Decibel Therapeutics | 0.3 | $4.9M | 1.6M | 3.02 | |
Vaccitech Ads (BRNS) | 0.2 | $3.4M | 1.5M | 2.24 | |
Foghorn Therapeutics (FHTX) | 0.2 | $3.1M | 501k | 6.20 | |
Magenta Therapeutics | 0.1 | $2.6M | 3.3M | 0.79 | |
Tenaya Therapeutics (TNYA) | 0.1 | $2.6M | 916k | 2.85 | |
Vera Therapeutics Cl A (VERA) | 0.1 | $2.3M | 302k | 7.76 | |
Rani Therapeutics Hldgs Com Cl A (RANI) | 0.1 | $2.3M | 449k | 5.16 | |
Tscan Therapeutics (TCRX) | 0.1 | $2.3M | 1.1M | 2.10 | |
Kronos Bio (KRON) | 0.1 | $2.1M | 1.4M | 1.46 | |
EXACT Sciences Corporation (EXAS) | 0.1 | $1.6M | 23k | 67.81 | |
Hyperfine Com Cl A (HYPR) | 0.1 | $1.3M | 899k | 1.44 | |
Spero Therapeutics (SPRO) | 0.1 | $1.3M | 890k | 1.45 | |
Autolus Therapeutics Spon Adr (AUTL) | 0.1 | $1.3M | 698k | 1.84 | |
Alector (ALEC) | 0.1 | $1.1M | 176k | 6.19 | |
Science 37 Holdings | 0.0 | $898k | 3.2M | 0.28 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.0 | $513k | 641k | 0.80 | |
Oportun Finl Corp (OPRT) | 0.0 | $366k | 95k | 3.86 | |
Invitae (NVTAQ) | 0.0 | $318k | 236k | 1.35 | |
Cortexyme (QNCX) | 0.0 | $295k | 189k | 1.56 | |
Mondee Holdings Class A Com (MOND) | 0.0 | $206k | 18k | 11.16 | |
Evelo Biosciences | 0.0 | $191k | 1.1M | 0.18 | |
Repligen Corporation (RGEN) | 0.0 | $65k | 383.00 | 168.36 | |
Cue Health (HLTHQ) | 0.0 | $49k | 27k | 1.82 | |
Fulcrum Therapeutics (FULC) | 0.0 | $41k | 14k | 2.85 |